Atlas Trials

Study to Investigate Single Ascending Oral Doses of AZD5213 in Healthy Male and Non Fertile Female Subjects

Clinical trial NCT01121302 · COMPLETED

Trial details

NCT number
NCT01121302
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Tolerability
Start date
2010-05-01
Primary completion
2010-12-01
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.